Scientists at St. Jude Children’s Research Hospital have used positron emission tomography (PET) with edaravone, a drug used ...

NYT's Connections puzzle challenges players to group 16 words into four thematic categories, with difficulty levels requiring ...

Experts warn that difficulty swallowing, producing excess saliva or even drooling could be a sign of motor neurone disease ...

Circuits in the brain that are crucially involved in implementing decisions by directing between perseverance, exploration ...

The early diagnosis of Alzheimer’s disease (AD) through the detection of p-tau proteins in the blood is less disease-specific ...

For the early detection of Alzheimer's disease, so-called p-tau proteins in the blood are not as disease-specific as ...

Researchers have revealed neural circuits in the brainstem that are crucially involved in implementing decisions by ...

Ivor Elrifi, CEO of Tiziana Life Sciences, expressed enthusiasm about this milestone, stating, "We are excited to initiate this important clinical study with the support of the ALS Association grant.

NEW YORK, March 04, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully hu ...

Studies have long warned that women are at a disproportionately higher risk of developing the memory-robbing condition ...

"Receiving orphan drug designation from the FDA is a significant milestone for DiagnaMed and validates the promise of molecular hydrogen as a potential treatment for ALS. We are excited to partner ...

In addition to the patent, Revive also gets the intellectual and work property derived from DiagnaMed’s research activities ...